Concert Pharmaceuticals

About:

Concert Pharmaceuticals is a biotechnology company that uses deuterium chemistry to develop drug products that address patient needs.

Website: http://www.concertpharma.com

Twitter/X: ConcertPharma

Top Investors: Hercules Capital, RA Capital Management, Biotechnology Value Fund, GlaxoSmithKline, Greylock

Description:

Concert Pharmaceuticals is a clinical-stage biotechnology company dedicated to creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium. Concert applies its innovative precision deuterium chemistry platform to modify specific properties of validated drug molecules, yielding a rich pipeline of new chemical entities (NCEs). Concert leverages decades of pharmaceutical experience to create novel drug candidates with the potential for efficacy and safety, while greatly reducing R&D risk, time, and expense.